A Cross-sectional, Retrospective Screening and Case-control Study Examining the Frequency of, and Risk Factors Associated With, Impulse Control Disorders in Parkinson's Disease Patients Treated With MIRAPEX® (Pramipexole) and Other Anti-parkinson Agents (DOMINION Study)
Phase of Trial: Phase IV
Latest Information Update: 12 Nov 2013
At a glance
- Drugs Antiparkinsonians; Pramipexole
- Indications Parkinson's disease
- Focus Adverse reactions
- Acronyms DOMINION
- 24 Jun 2010 Actual end date (Sep 2006) added as reported by ClinicalTrials.gov.
- 24 Jun 2010 Actual initiation date (Jan 2008) added as reported by ClinicalTrials.gov.
- 16 Mar 2008 New trial record.